COXI
COXI
Authorised
- Diclazuril
Product identification
Medicine name:
COXI
Active substance:
- Diclazuril
Target species:
-
Pigeon
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Diclazuril2.50/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Pigeon
-
All relevant tissues99999dayPigeons not intended for human consumption.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP51AJ03
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Romania
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Veterinary medicinal products intended for animals exclusively kept as pets (article 5(6) of Reg 2019/6)
Marketing authorisation holder:
- Belgica De Weerd B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Belgica De Weerd B.V.
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 200214
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
Romanian (PDF)
Published on: 29/12/2021
How useful was this page?:
